Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Skin cancer diagnostics

Study on AI-assisted melanoma detection.

    • Congress Reports
    • Dermatology and venereology
    • Oncology
    • Prevention and health care
    • RX
    • Studies
  • 2 minute read

Early detection of malignant melanoma is of critical prognostic importance. To improve sensitivity and specificity, a variety of other noninvasive diagnostic methods are now available in addition to sequential digital dermoscopy, including deep learning models.

In a retrospective cross-sectional study, neural networks (“convolutional neural networks” CNN) developed for image-based diagnostic classification of skin lesions were compared with the sequential monitoring strategy [1–3]. Image quartets of 59 high-risk patients, each with three nevi and one melanoma originally diagnosed on the basis of sequential changes by digital dermoscopy, were used as test material [3]. Two validated neural networks were used to evaluate image quartets at baseline and at the time of melanoma diagnosis. In addition, the baseline quartets were evaluated by 26 dermatologists. Relevant target criterion was the number of quartets with completely correct classification.

Study results and conclusion

At baseline, the networks correctly classified all lesions in 15.3% and 13.6% of the 59 quartets, respectively [3]. This corresponded to a sensitivity of 25.4% and 28.8% and a specificity of 92.7% and 75.7%, respectively. After sequential monitoring at the time of melanoma diagnosis, sensitivity improved to 44.1% and 49.2%, respectively, due to the development of additional morphologic melanoma features. Dermatologists correctly classified an average of 24 (22-27) of the 59 quartets at baseline, and you had been told that each quartet contained exactly one melanoma. In an alternative evaluation of the CNN results, a quartet was already considered correctly classified as soon as the melanoma was assigned the highest malignancy score in the quartet. Under this approach, the two CNNs correctly classified 28 (47.5%) and 22 (37.3%) of the 59 baseline quartets, respectively. The conclusion of the study authors is, on the one hand, that the neural networks studied could not replace the sequential monitoring strategy for melanoma detection and, on the other hand, dermatologists and neural network together seem to achieve better diagnostic performance in sequential melanoma detection [3].

Congress: DDG compact and practical

 

Literature:

  1. Sies K: JDDG 2021; 19(6): 842-851.
  2. Jutzi TB, Brinker TJ: Dtsch Arztebl 2020; 117(24): [14]; DOI: 10.3238/PersDerma.2020.06.12.03
  3. Winkler J, et al: Can neural networks replace sequential digital dermoscopy in high-risk patients? Dermatologie kompakt und praxisnah 18-20.02.2022, abstract volume, P015.

DERMATOLOGY PRACTICE 2022; 32(3): 38

Autoren
  • Mirjam Peter, M.Sc.
Publikation
  • DERMATOLOGIE PRAXIS
Related Topics
  • Artificial Intelligence
  • Artificial intelligence
  • convolutional neural networks
  • DDG compact and practical
  • Diagnostics
  • High-risk patients
  • JDDG
  • Melanoma
  • Melanoma Detection
  • practice management
  • Sies
  • Skin cancer
Previous Article
  • Zeposia

Protected: Safety profile and tolerance – Profil de sécurité et tolerance

  • Partner Content
  • RX
View Post
Next Article
  • View of the effectiveness - Aperçu de l'efficacité

Protected: Die TRUE NORTH Studie – L’étude TRUE NORTH

  • Partner Content
  • RX
View Post
You May Also Like
View Post
  • 9 min
  • Atopic Dermatitis: Precisely Targeting Immunological Targets

Interleukin blockade or OX40-(L) inhibition?

    • RX
    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Studies
View Post
  • 14 min
  • Fibromyalgia Syndrome

Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

    • General Internal Medicine
    • CME continuing education
    • Geriatrics
    • Neurology
    • Orthopedics
    • Rheumatology
    • RX
View Post
  • 27 min
  • Across All Types of Cancer

Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings

    • RX
    • CME continuing education
    • General Internal Medicine
    • Geriatrics
    • Hematology
    • Oncology
    • Pediatrics
    • Physical medicine and rehabilitation
    • Prevention and health care
    • Studies
View Post
  • 8 min
  • Obesity: More than half of those affected have fatty liver disease

From screening to multimodal intervention with GLP-1-RA or resmetirom

    • RX
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Studies
View Post
  • 6 min
  • Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib

First-class immunomodulation combined with convenience—the data available so far is convincing

    • RX
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • Studies
View Post
  • 4 min
  • Preclinical Study on a Special Ginkgo biloba Extract

What role do proanthocyanidins play?

    • RX
    • Education
    • General Internal Medicine
    • Geriatrics
    • Neurology
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
View Post
  • 6 min
  • Myasthenia gravis: immunomodulatory therapies for long-term treatment

Expanded Possibilities Thanks to Innovative Classes of Active Ingredients

    • RX
    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Ophthalmology
    • Studies
View Post
  • 10 min
  • Interstitial Lung Diseases

Update on Idiopathic Pulmonary Fibrosis

    • RX
    • CME continuing education
    • Pneumology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
  • 2
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 3
    Update on Idiopathic Pulmonary Fibrosis
  • 4
    Update on Idiopathic Pulmonary Fibrosis
  • 5
    Current status of PAT

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.